CN101249183A - Capsules for curing hypertension and condensed blood lipid - Google Patents
Capsules for curing hypertension and condensed blood lipid Download PDFInfo
- Publication number
- CN101249183A CN101249183A CNA2008100494538A CN200810049453A CN101249183A CN 101249183 A CN101249183 A CN 101249183A CN A2008100494538 A CNA2008100494538 A CN A2008100494538A CN 200810049453 A CN200810049453 A CN 200810049453A CN 101249183 A CN101249183 A CN 101249183A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- capsule
- hypertension
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a capsule for treating hypertension and hyperlipidemia, which is a medicine for treating hypertension, and overcomes the disadvantages in the other technologies. The medicine is made from the medicines as follows: whole scorpion is 3g, centipede is 3, radix codonopsitis is 14g, Astragalus roots are 9g, rhizoma ligustici wallichii is 9g, cinnamon is 9g, homalomena rhizome is 12g, radix ligustici sinensis is 9g, radix saposhinikoviae is 9g, angelica dahurica is 12g, cassia twig is 9g, wild celery is 9g, and Spica Schizonepetae is 9g. The invention has a preparation method that: through the original formulation dose (raw ingredient traditional Chinese medicines), the medicine components are screened and purified, and then are crushed and grinded into medicinal powders according with a powder standard by a machine; the medicinal powders pass through a screen with 120 screen meshes, and encapsuled into No.1 capsules, and 0.25g medicinal powders are encapsuled in each capsule. 1300 cases are treated in all through diagnosis and treatment in decades, and the cure rate can reach 98 percent.
Description
One, technical field:
The present invention relates to a kind of medicine for the treatment of hypertension, especially a kind of capsule for the treatment of hypertension and thick blood fat disease.
Two, background technology:
Suffer from the numerous of hypertension and thick blood fat at present, the medicine of treatment hypertension and thick blood fat is also varied,, all cures the symptoms, not the disease the medical expense height though these medicines can play certain curative effect.
Three, summary of the invention:
The purpose of this invention is to provide a kind of capsule for the treatment of hypertension and thick blood fat disease that therapeutic effect is good and can not recur, it has overcome the shortcoming that other technology exists, the object of the present invention is achieved like this, it is made by following medicine, Scorpio 3g, 3 of Scolopendras, Radix Codonopsis 14g, Radix Astragali 9g, Rhizoma Chuanxiong 9g, Cortex Cinnamomi 9g, Rhizoma Homalomenae 12g, Rhizoma Ligustici 9g, Radix Saposhnikoviae 9g, Radix Angelicae Dahuricae 12g, Ramulus Cinnamomi 9g, Radix Angelicae Pubescentis 9g, mustard fringe 9g.
Preparation method is that by former dosage form dose (raw material Chinese medicine), screening purifies, and makes the medicated powder that meets the powder standard with the machine pulverising mill then, crosses 120 mesh sieves, refills capsule No. one, each capsules powder charge powder 0.25 gram.
Each pharmaceutical analysis in the prescription: 1, Scorpio: meridian distribution of property and flavor; Xin Ping is poisonous: return Liver Channel.Effect: endogenous wind stopping relieving convulsion, detoxicating and resolving stagnation of pathogens, removing obstruction in the collateral to relieve pain.2, Scolopendra: meridian distribution of property and flavor; Xin Wen is poisonous: return Liver Channel.Effect: endogenous wind stopping relieving convulsion, detoxicating and resolving stagnation of pathogens, removing obstruction in the collateral to relieve pain.3, Radix Codonopsis: meridian distribution of property and flavor; Sweet flat, return spleen, lung meridian.Effect: invigorating the spleen and replenishing QI, it is foster to promote the production of body fluid.4, the Radix Astragali: meridian distribution of property and flavor; Sweet tepor; Return spleen, lung meridian; Effect: tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, diuretic detumescent.5, Rhizoma Chuanxiong: meridian distribution of property and flavor: Xin Wen; Return liver, gallbladder, pericardium channel.Effect: blood-activating and qi-promoting, wind-expelling pain-stopping.6, Cortex Cinnamomi: meridian distribution of property and flavor, Xin Ganre; Return kidney, spleen, the heart, Liver Channel.Effect: it is supporing yang to mend fire, dispersing cold for relieving pain, the logical vein of temperature.7, Rhizoma Homalomenae: meridian distribution of property and flavor, toil temperature; Return liver, kidney channel.Effect: wind-damp dispelling, muscle reinforcing and bone strengthening, the meridian dredging.8, Rhizoma Ligustici: meridian distribution of property and flavor; Xin Wen; Return urinary bladder channel.Effect: deliver cold expelling, expelling wind and dampness, pain relieving.9, Radix Saposhnikoviae: meridian distribution of property and flavor; Hot sweet tepor; Return bladder, liver, spleen channel.Effect: expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic.10, the Radix Angelicae Dahuricae: meridian distribution of property and flavor, Xin Wen; Attach to the lung and stomach meridians.Effect: induce sweat dispeiling pathogenic wind and removing dampness, detumescence and apocenosis, pain relieving.11, Ramulus Cinnamomi: meridian distribution of property and flavor, Xin Ganwen; GUIXIN, lung, urinary bladder channel.Effect: relieving the exterior syndrome by diaphoresis, warming the meridian for promoting the flow of YANG QI.12, Radix Angelicae Pubescentis: meridian distribution of property and flavor, arduous temperature; Return liver, kidney, urinary bladder channel.Effect, wind-damp dispelling, induce sweat, pain relieving.13, mustard fringe: meridian distribution of property and flavor, hot, tepor; Return lung, Liver Channel.Effect: expelling pathogenic wind from the body surface, the diffusing saturating stasis of blood of a surname, hemostasis.
Function cures mainly: the sequela of hypertension, thick blood fat, hypotension and formation (being hemiplegia, as diseases such as facial hemiparalysis, numb limbs and tense tendons, hemiplegias) also has significant curative effect to rheumatism disease disease.
Mechanism: 1, delaying human body cell tissue aging, the hypertension incidence principle is blocked in the sclerosis of prevention artery, reaches the effect for the treatment of both the principal and secondary aspects of a disease.2, reduce serum cholesterol rapidly, thereby effectively reduce the incidence probability of cardiovascular and cerebrovascular vessel.3, effectively suppress to take Western medicine and reduce various untoward reaction and complication and the side effect that is produced.4, the clinical observation adverse reaction rate is zero, and the heart, brain, kidney, bone etc. are set upright the repairing effect.5, our medicine can change the thick stagnant phenomenon of condensing of blood, repairs and improves blood vessel, consolidates positive source.6, overcome untoward reaction and drug dependence that the life-time service chemical drugs causes, blood has been maintained a long-term stability, never repeatedly.The blood pressure blood fat is reached normally, and after treatment can break away from medicine in addition, need not take medicine for a long time.
7, this prescription cost is low, simple for production, curative effect time short, the cure rate height, and this type of medicine can reach also not having of radical cure both at home and abroad at present, so this medicine has been filled up this blank.
Instructions of taking and consumption: the treatment that takes this medicine is according to the three phases treatment course of treatment: control the stage temporarily, in the treating both the principal and secondary aspects of a disease stage, consolidate the curative effect stage.Divide every day and take medicine for three times, take three to six at every turn, general three to seven days take effect, and reach normal, controlled substantially in 15 to 20 days, improve blood quality, the softening blood vessel of repairing.Make organs such as the heart, brain, kidney,liver,spleen obtain setting upright repairing by continuing medication, fundamentally remove cause of disease, make blood, blood fat, reach normal.Consolidate medication again, thoroughly recover self each organ ability, improve autoimmunity, do not rebound thereby reach, the effect that does not recur need not be taken medicine for a long time.The blood pressure patient can easily be lived, be without fear of an attack from the rear again.
Medication taboo: at period in a medicine, forbid to drink and spirituosity class article, eat pungent, greasy food less.
The patient source: the general hospital transfers 680 people, and professional outpatient service transfers 620 people.
Analysis of cases: 35 years old-45 years old 150 examples; 46 years old-55 years old 450 examples; 550 examples in 56-65 year; 150 examples of over-65s.
Male's 750 examples of seeing and treating patients; Women's 550 examples.
Through the diagnoses and treatment of decades, 1300 examples of seeing and treating patients altogether, cure rate 98%.
Four, the specific embodiment:
The present invention is made by following medicine, Scorpio 3g, 3 of Scolopendras, Radix Codonopsis 14g, Radix Astragali 9g, Rhizoma Chuanxiong 9g, Cortex Cinnamomi 9g, Rhizoma Homalomenae 12g, Rhizoma Ligustici 9g, Radix Saposhnikoviae 9g, Radix Angelicae Dahuricae 12g, Ramulus Cinnamomi 9g, Radix Angelicae Pubescentis 9g, mustard fringe 9g.
Preparation method is, by former dosage form dose (raw material Chinese medicine), screening purifies, and makes the medicated powder that meets the powder standard with the machine pulverising mill then, crosses 120 mesh sieves, and refilling is a capsule, and each capsules powder charge powder 0.25 restrains.
Claims (2)
1. capsule for the treatment of hypertension and thick blood fat disease, it is characterized in that: make Scorpio 3g, 3 of Scolopendras, Radix Codonopsis 14g, Radix Astragali 9g, Rhizoma Chuanxiong 9g, Cortex Cinnamomi 9g, Rhizoma Homalomenae 12g, Rhizoma Ligustici 9g, Radix Saposhnikoviae 9g, Radix Angelicae Dahuricae 12g, Ramulus Cinnamomi 9g, Radix Angelicae Pubescentis 9g and mustard fringe 9g by following medicine.
2. according to described a kind of treatment hypertension of claim 1 and the sick capsular preparation method of thick blood fat, it is characterized in that: by former dosage form dose, screening purifies, make the medicated powder that meets the powder standard with the machine pulverising mill then, cross 120 mesh sieves, refilling is a capsule, each capsules powder charge powder 0.25 gram.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100494538A CN101249183A (en) | 2008-04-01 | 2008-04-01 | Capsules for curing hypertension and condensed blood lipid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100494538A CN101249183A (en) | 2008-04-01 | 2008-04-01 | Capsules for curing hypertension and condensed blood lipid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101249183A true CN101249183A (en) | 2008-08-27 |
Family
ID=39952893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100494538A Pending CN101249183A (en) | 2008-04-01 | 2008-04-01 | Capsules for curing hypertension and condensed blood lipid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101249183A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526617A (en) * | 2012-01-12 | 2012-07-04 | 马金桥 | Chinese herbal medicine powder for lipid reduction and thrombolysis |
CN102727773A (en) * | 2012-07-03 | 2012-10-17 | 许瑞琴 | Traditional Chinese medicinal capsule for treating blood mucoviscidosis |
-
2008
- 2008-04-01 CN CNA2008100494538A patent/CN101249183A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526617A (en) * | 2012-01-12 | 2012-07-04 | 马金桥 | Chinese herbal medicine powder for lipid reduction and thrombolysis |
CN102526617B (en) * | 2012-01-12 | 2013-09-25 | 马金桥 | Chinese herbal medicine powder for lipid reduction and thrombolysis |
CN102727773A (en) * | 2012-07-03 | 2012-10-17 | 许瑞琴 | Traditional Chinese medicinal capsule for treating blood mucoviscidosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101485836A (en) | Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof | |
CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
CN100444888C (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
CN101112533B (en) | A Chinese medicinal composition for treating and preventing gout, and its preparation method | |
CN1052889C (en) | Chinese proprietary for curing hepatitis | |
CN101249183A (en) | Capsules for curing hypertension and condensed blood lipid | |
CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
CN105748646A (en) | Traditional Chinese medicine composition for treating pain in neck or shoulders or waist or legs and preparation method thereof | |
CN101837111A (en) | Medicament for curing proliferation of mammary glands and preparation method thereof | |
CN105770294A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
CN101721483A (en) | Traditional Chinese medicine for treating prolapse of lumbar intervertebral disc | |
CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
CN102824461A (en) | Medicine for treating hypertension and preparation method thereof | |
CN108186720A (en) | A kind of pharmaceutical composition and its preparation method and application | |
CN103520574B (en) | A kind of Chinese medicine for the treatment of chronic hepatitis | |
CN103356951B (en) | A kind of Chinese medicine composition for the treatment of cardiac blood supply deficiency | |
CN1994415B (en) | Orally administered Chinese medicine for treating dysmenorrhea | |
CN102068647A (en) | Chinese medicinal composition for treating lumbocrural pains by ironing and warming | |
CN100353995C (en) | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin | |
CN101530598A (en) | Plaster used for hyperosteogeny | |
CN105663850A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
CN105250856A (en) | Chinese herb composition for treating climacteric syndrome | |
CN100333780C (en) | Chinese medicine for antisenility and its preparation method | |
CN104800703A (en) | Traditional Chinese medicine composition for treating irregular menstruation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20080827 |